SCHEMBL29958664

SCHEMBL29958664

COC(=O)Cc1cc(Cl)ccc1C#N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.46
KDM4E B2RXH2 2/20 0.46
GAA P10253 2/20 0.46
CYP1A2 P05177 1/20 0.46
GLA P06280 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
ADRA1D P25100 1/20 0.43
F2 P00734 1/20 0.43
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
HPGD P15428 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NOS3 P29474 6/20 0.42
NOS1 P29475 6/20 0.42
NOS2 P35228 6/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27033421 1.00 MAPT (0.46) MAPTKDM4EGAACYP1A2GLA
SCHEMBL28068640 0.88 HPGD (0.45) MAPTKDM4EGAACYP1A2GLA
SCHEMBL29174264 0.82 ADRA1D (0.35) MAPTKDM4EGAACYP1A2GLA
SCHEMBL25244289 0.82 KDM4E (0.46) MAPTKDM4EGAACYP1A2GLA
SCHEMBL30711675 0.81 ADRA1D (0.47) MAPTCYP2C9ADRA1DF2NOS3
SCHEMBL27033537 0.81 ADRA1D (0.47) MAPTCYP2C9ADRA1DF2NOS3
SCHEMBL27033816 0.80 ADRA1D (0.52) ADRA1DF2NOS3NOS1NOS2
SCHEMBL30711627 0.80 ADRA1D (0.52) ADRA1DF2NOS3NOS1NOS2
SCHEMBL7133160 0.79 MAPT (0.49) MAPTKDM4EGAACYP1A2CYP3A4
Lithium Ion SCHEMBL29174263 0.78 ADRA1D (0.45) MAPTCYP2C9ADRA1DF2NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308228-A1 PLASMA KALLIKREIN INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2024-01-24 EP disclosed
WO-2022197756-A1 PLASMA KALLIKREIN INHIBITORS SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 WO disclosed